Gut Microbiome Profiles in Women With Gynecological Tumors and Pelvic Toxicity
Comparing Controls and Effects of Rectal Ozone Therapy
Led by Bernardino Clavo, MD, PhD · Updated on 2026-09-23
38
Participants Needed
2
Research Sites
10 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating pelvic toxicity that can develop in women treated for gynecological tumors with radiotherapy and chemotherapy. This condition affects the rectum, bladder, and vagina, causing symptoms like proctitis, cystitis, and mucositis, which significantly reduce quality of life. The study aims to explore how the gut microbiome relates to this pelvic toxicity and to the effects of rectal ozone therapy, which is used compassionately for refractory cases with notable symptom improvement.
The study observes two groups women with chronic pelvic toxicity receiving compassionate rectal ozone therapy and a control group matched by age and tumor location without toxicity. Samples and data on gut microbiome composition and diversity will be collected before and after ozone therapy in the treatment group and once during a follow-up visit for controls. The study will assess changes in the microbiome, severity of toxicity, and responses to therapy over four months.
Participants will be assessed through sample collection and clinical data at baseline and follow-up visits. Researchers will measure gut microbiome profiles, pelvic toxicity grades, quality of life, mood symptoms, and biochemical markers of oxidative stress and inflammation. The study will provide insights into the relationship between microbiome changes and pelvic toxicity, with participation lasting up to four months after ozone treatment for cases.
CONDITIONS
Brief Title
Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)
Research Team
B
Bernardino Clavo, MD, PhD
F
Francisco Rodríguez-Esparragón, BSc, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Hospital Universitario de Gran Canaria Doctor Negrín
Collaborating Sponsor
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
Adult women aged 18 years or older
Diagnosed with gynecological tumors of any location and stage
Previously treated with radiotherapy and/or chemotherapy
Provided signed informed consent for the study
For the pelvic toxicity group: chronic pelvic toxicity lasting 3 months or more after usual treatment
For the pelvic toxicity group: toxicity grade 2 or higher according to CTCAE v.5.0
You will not qualify if you...
Not meeting all inclusion criteria
Active inflammatory bowel disease (e.g., Crohn's Disease, Ulcerative Colitis) or history of major gastrointestinal resection excluding appendectomy
Uncontrolled illness or psychiatric condition limiting study compliance or data interpretation
Unwilling or unable to provide written informed consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Observation and Sample Collection
Duration - Up to 4 months
Participants with pelvic toxicity receiving rectal ozone therapy will have samples and data collected before and after treatment. Control participants will provide samples during a follow-up visit.
1 to 2 visits depending on group assignment
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Comparing 3-Needle and 5-Needle Genicular Nerve Blocks for Pain and Quality of Life in Knee Osteoarthritis
Phase 2 Study of TQB2102 Injection for Women With Advanced Recurrent or Metastatic Gynecological Tumors Evaluating Safety and Effectiveness
Community-Based Digital and Behavioral Management for Nocturia in Older Adults
Web-Based Light, Activity, and Sleep Program to Improve Quality of Life in Adults 70 and Older
New Radiation Targeting Method to Improve Survival and Reduce Side Effects in Adults With High-grade Glioma A Randomized Single-blind Clinical Trial
Randomized Trial of Peer-Led CARE Intervention to Improve Health and Reduce Cardiovascular Risks in Women Ages 18 to 49 in Texas Communities
Study of Brain Stimulation and Virtual Reality Cognitive Training to Improve Thinking and Mood in Adults 55 and Older with Mild Cognitive Impairment
Phase 2 Study of Enalapril for Adults Aged 18 to 70 With Painful Venous Malformations to Reduce Pain and Improve Quality of Life
Phase I Study to Find the Best Dose of Lisinopril to Prevent Urinary Problems After Radiotherapy for Prostate Cancer in Men
Acceptance and Commitment Therapy to Support Mental Health and Transition Readiness
in Black Adolescents and Young Adults with Sickle Cell Disease